Siemens Healthmakers Launch ACUSON Origin, Circular Cardiovascular Revolutionary System In RI

Photo: Special

JAKARTA - The number of patients with heart disease and its complexity is increasing rapidly throughout the world.

Even from 2012 to 2030, it is estimated that the number of people with heart failure has increased by 46 percent.

Not only that, the annual growth combined structural heart intervention is also projected to increase by 9.15 percent.

This is supported by a variety of new therapies for the closure of the left-handed cap of the heart and a number of devices designed to treat patients with triuspid regulation.

To deal with diagnostic and intervention cases like this and other cases that occur when clinical and ultrasound personnel are inadequate, health institutions need advanced new cardiovascular tools.

At the Indonesian Society of Echocardiography (ISE) annual event, Siemens Healthmakers launched Acuson Origin, a revolutionary ecocardiographic system designed to change the world of cardiovascular imaging in Indonesia.

The launch of this tool marks an important milestone in the progress of cardiovascular care in the country.

Acuson Origin is claimed to be designed to simplify and facilitate decision making in cardiac examination so that the results of the examination are more consistent, accurate, and efficient.

"Acuson Origin's launch in Indonesia is proof of our commitment to providing the best tools for health professionals in increasing patient care. We believe this advanced ecocardiographic system will have a significant impact on cardiovascular diagnostics in Indonesia," said Alfred Fahringer, Country Head of Siemens Healthmakers Indonesia.

Acuson Origin is said to be able to automatically measure and calculate all four heart rooms without the need for EKG through the 2D and 4D HeartAI features.

With the support of the latest artificial intelligence, the 2D HeartAI feature is able to automatically track contrasts to images.

It is this ability that makes Acuson Origin the only system that has it.

The 4D HeartAI technology is a sophisticated breakthrough that can process heart data with precision.

This tool immediately calculates the size and performance of the four heart rooms.

This technology is 96 percent very accurate in measuring the final volume of left-ventricle diastolic (LV LED) and blood volume during diastolic pressure (ES), both by using transtorated Ecocardiograms (TTE) and Transesofageal Ecocardiography (TEE).

In addition, 4D HeartAI also has an accuracy rate of 98 percent for Multi-planar Reconstruction (MPR).

This system is a pioneer in its field that can recognize the heart position in real-time.

Its AI Assist feature is able to recognize 12 transtorated Ekokardiogram cardiac positions (TTE) with an accuracy rate of 99 percent.

Acuson Origin uses artificial intelligence technology to improve the accuracy and efficiency of diagnostics.

This system is equipped with an automatic measurement feature of more than 5,600 types.

This feature increases accuracy and speed in analyzing medical data, so that the results of the examination are more trusted.

As a result, the clinical decision-making process becomes more effective.

"We are proud to be able to support the presence of Acuson Origin for members and the medical community at large. This innovative system will help health workers provide a more accurate diagnosis and better treatment results for heart disease patients," said BRM Ario Soeryo Kuncoro, Chairman of the Indonesian Society of Echocardiography.